Biofrontera, Inc. (BFRI)
1.56
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 15:35
Biofrontera Price to Book Value : 3.721 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.721 |
| September 04, 2026 | 3.840 |
| September 03, 2026 | 3.602 |
| September 02, 2026 | 3.625 |
| September 01, 2026 | 3.661 |
| August 31, 2026 | 3.649 |
| August 28, 2026 | 3.792 |
| August 27, 2026 | 3.554 |
| August 26, 2026 | 3.649 |
| August 25, 2026 | 3.602 |
| August 24, 2026 | 3.482 |
| August 21, 2026 | 3.53 |
| August 20, 2026 | 3.53 |
| August 19, 2026 | 3.387 |
| August 18, 2026 | 3.435 |
| August 17, 2026 | 3.220 |
| August 14, 2026 | 3.101 |
| August 13, 2026 | 3.005 |
| August 12, 2026 | 2.981 |
| August 11, 2026 | 2.910 |
| August 10, 2026 | 2.886 |
| August 07, 2026 | 3.029 |
| August 06, 2026 | 2.981 |
| August 05, 2026 | 2.958 |
| August 04, 2026 | 2.910 |
| Date | Value |
|---|---|
| August 03, 2026 | 2.838 |
| July 31, 2026 | 2.791 |
| July 30, 2026 | 2.934 |
| July 29, 2026 | 2.791 |
| July 28, 2026 | 2.648 |
| July 27, 2026 | 2.504 |
| July 24, 2026 | 2.600 |
| July 23, 2026 | 2.600 |
| July 22, 2026 | 2.576 |
| July 21, 2026 | 2.576 |
| July 20, 2026 | 2.504 |
| July 17, 2026 | 2.600 |
| July 16, 2026 | 2.648 |
| July 15, 2026 | 2.600 |
| July 14, 2026 | 2.528 |
| July 13, 2026 | 2.648 |
| July 10, 2026 | 2.624 |
| July 09, 2026 | 2.719 |
| July 08, 2026 | 2.719 |
| July 07, 2026 | 2.767 |
| July 06, 2026 | 2.767 |
| July 02, 2026 | 2.409 |
| July 01, 2026 | 2.409 |
| June 30, 2026 | 2.255 |
| June 29, 2026 | 1.995 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.693 |
| Corcept Therapeutics, Inc. | 17.62 |
| Veru, Inc. | 1.514 |
| Johnson & Johnson | 7.596 |
| Eli Lilly & Co. | 31.27 |
Price to Book Value Related Metrics
| PS Ratio | 0.3972 |
| Price | 1.56 |
| Earnings Yield | -37.58% |
| Market Cap | 22.16M |